UnitedHealthcare will eliminate prior authorization requirements for 30% of healthcare services by the end of 2026, a significant move aimed at simplifying processes for patients and providers.
“Prior authorization is an essential safeguard but should only be used when it truly protects patients and improves care,” Tim Noel, CEO of UnitedHealthcare, said in a May 5 statement.
The cuts will apply to select outpatient surgeries, certain diagnostic tests like echocardiograms, and some outpatient therapies and chiropractic care. The company noted that prior authorization is currently required for only 2% of its medical services, with about 92% of those requests approved in less than 24 hours on average.
The policy shift comes as insurers navigate a challenging post-subsidy ACA market, with many, including UnitedHealthcare, shrinking their marketplace presence to protect margins. While reducing administrative hurdles may improve provider relations, it also introduces uncertainty over future claim costs.
The announcement is the latest in a series of changes from the nation's largest insurer. On April 24, UnitedHealthcare led an effort to standardize electronic prior authorization submissions to increase automation. The company also recently expanded support for rural healthcare providers by exempting many from prior authorization requirements and accelerating payments to improve financial stability for facilities in underserved areas.
The move occurs in a turbulent market for health insurers. Following the expiration of enhanced ACA subsidies, many carriers have raised premiums and seen their member mix shift toward higher-acuity patients, as noted in recent earnings reports from peers like Centene. UnitedHealthcare itself expects to shrink its ACA enrollment by about a third in 2026 to focus on margin recovery, after pledging to rebate any 2026 profits from its individual ACA plans.
For UnitedHealthcare, this reduction in prior authorizations could lower administrative overhead and strengthen its network relationships at a critical time. The next catalyst for investors will be the company's second-quarter earnings report, which will provide the first glimpse into how such policy changes are affecting the company's medical loss ratio and overall profitability.
This article is for informational purposes only and does not constitute investment advice.
